Ocu-Sul 30 Side Effects
Generic name: sulfacetamide sodium ophthalmic
Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.
Note: This document provides detailed information about Ocu-Sul 30.
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension Side Effects associated with sulfacetamide sodium ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Ocu-Sul 30.
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension.
Side effects include:
Local irritation, transient stinging or burning.
For healthcare professionals
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution.
General
The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]
Ocular
- Frequency not reported: Local/conjunctival irritation, stinging, burning, nonspecific conjunctivitis, conjunctival hyperemia, bacterial corneal ulcers, fungal corneal ulcers[Ref]
Hypersensitivity
- Rare (less than 0.1%): Sensitivity reactions
- Frequency not reported: Allergic reactions/hypersensitivity, local hypersensitivity progressing to fatal syndrome resembling systemic lupus erythematosus (SLE)[Ref]
At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]
Other
- Frequency not reported: Secondary infections[Ref]
Dermatologic
- Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).
Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]
Hematologic
Sulfonamides:
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
Hepatic
Sulfonamides:
- Frequency not reported: Fulminant hepatic necrosis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
References
1. "Product Information. Sodium Sulamyd (sulfacetamide sodium ophthalmic)." Schering Corporation
2. Cerner Multum, Inc. "Australian Product Information."
More about Ocu-Sul 30 (sulfacetamide sodium ophthalmic)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: ophthalmic anti-infectives
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Ocu-Sul 30 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.